This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Dual Therapy Stent Market

Dual Therapy Stent Market

Dual Therapy Stent Market Forecast, Trend, Analysis & Competition Tracking - Global Market Insights 2021 to 2031

Dual Therapy Stent Market
FACT572MR

Dual Therapy Stent Market Overview

Cardiovascular diseases around the world have observed an alarming growth in recent years. According to WHO, 17.9 million people die due to coronary heart diseases (heart attacks) and cerebrovascular (strokes) every year.

Family history, high cholesterol, smoking, high blood pressure (hypertension), imbalanced diet, obesity, lack of physical activity and substance abuse like excessive consumption of alcohol are the main reasons for suffering a heart attack. Younger adults are also prone to suffering from heart attacks due to family history and genetic factors that clots blood at an earlier age.

A patient suffering from a heart attack has higher cholesterol levels that creates plaque and clogs the arteries and stops the blood flow in the human body. Thus, the patient has to undergo surgery. To remove the clog and to accelerate the blood flow, dual therapy stents are used. This stent expands the artery to improve the blood flow. Stents help in reducing chest pain in patients and are used when a patient is suffering from severe pain.

Dual therapy stents are used in heart care hospitals, clinics and outpatient surgeries. Mostly, dual therapy stents are used without hesitation as the patient’s life is at risk. Dual therapy stents ensure relief at an early stage which makes the process more reliable for the patients.

Key Trends in Dual Therapy Stents Market

Everyday stress, high blood pressure and ignorance towards health have increased the risk of heart disease. The growth of fast food joints, exhausting work schedules and complete ignorance towards fitness has deteriorated healthy lifestyle in people across the globe.

Plus, reliability on fast and instant food has worsened the situation of increasing cholesterol levels in people. A fast-paced lifestyle increased the rate of heart attacks in the world. The increasing population demands more dual therapy stents in hospitals. Also, the dual therapy stents market can increase as it treats patients with complex lesions and atherosclerotic burden.

Know More Details About the Report

Decrease in Drug-elating Stents and Alternative Therapy Impeding Growth

Reasons that hamper the growth of the dual therapy market are alternative therapy processes, decrease in the pricing of drug-elating stents. The evolution of science has invented organic and dissolvable stents known as non-metallic stents.

These stents save the patients from the pain of removing the stent and undergoing surgery. Also, younger adults’ decision of consciously consuming food, choosing oil-free and sugar-free food has built a better immunity system for them. Plus, oil companies’ production and marketing of cholesterol-free oil aim to decrease health issues leading to lesser heart problems.

US Dual Therapy Stent Demand

The dual therapy stent market has been analyzed in North America, Latin America, the Middle East and Africa, Europe and Asia Pacific.

According to NCBI, North America may observe a surge in problems related to heart-related disease as lifestyle habits and nutritional deficiency are prevalent in North America.

Avail customized purchase options for your needs

Europe Dual Therapy Stent Market Outlook

Demand for dual therapy stent in Europe is likely to remain concentrated in UK, France, Germany, Spain, and Italy. The robust healthcare system in these countries is likely to provide an impetus to dual therapy stent market growth in these countries, and also in Europe overall.

The growth in the Asia Pacific regions for the dual therapy stent market is expected to increase as the governments are taking steps to provide health care to the residents of their country. This has been profitable for the dual therapy markets due to increasing investments from the governments.

Competitive Landscape

The top manufacturers of dual therapy stents are

  • Abbott
  • Boston Scientific
  • Cardinal Health
  • Cook Medical
  • Alvimedica
  • B.Braun
  • OrbusNeich
  • ORBUSNEICH Medtronic PLC
  • Ostial Corporation.

The dual therapy stent market exists with many players. Also, partnerships, mergers and acquisitions, different business ventures, government initiatives are proving to be a boon to the dual therapy stent market. Many companies are researching and are trying to improve the stents as patients are suffering severely.

An Adaptive Approach to Modern-day Research Needs

The Market Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional Analysis Includes:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Argentina, Chile, Peru)
  • Europe (UK, Germany, Spain, France, BENELUX, Italy, Rest of Europe)
  • East Asia (China, Japan, South Korea)
  • South Asia & Oceania (India, ASEAN, Australia and New Zealand, Rest of South Asia & Oceania)
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa, Turkey, Rest of MEA)

Have a report related query? Speak to us directly

Report Highlights:

  • A detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company

Segmentation

By use

  • Single-use
  • Multi-use

By Industry

  • Hospitals
  • Clinics

By Regions

  • North America,
  • Latin America,
  • The Middle East
  • Africa,
  • Europe 
  • Asia Pacific

Need an Exclusive Report for your Unique Requirement?

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.